Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 19, 2020

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Covid19
Interventions
DEVICE

Core Warming

Esophageal heat transfer device will be set to 42°C temperature after initial placement, and maintained at 42°C for the duration of treatment.

OTHER

Standard of Care

Standard temperature management and treatment

Trial Locations (1)

92123

Sharp Memorial Hospital, San Diego

All Listed Sponsors
collaborator

Advanced Cooling Therapy, Inc., d/b/a Attune Medical

INDUSTRY

lead

Sharp HealthCare

OTHER

NCT04494867 - Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation | Biotech Hunter | Biotech Hunter